Basic Information
Basic information for MIR9-3HG-212-19aa-1
Peptide Name MIR9-3HG-212-19aa-1
Genome Position chr15:89397118-89397174[+]
Species Human
Peptide Sequence MVDRSWLPVSFWADIAPLP
Peptide Length 19
Unique No (MIR9-3HG-201-19aa-1,MIR9-3HG-213-19aa-1,MIR9-3HG-214-19aa-3,MIR9-3HG-218-19aa-3,MIR9-3HG-219-19aa-3,MIR9-3HG-220-19aa-1,MIR9-3HG-221-19aa-1,MIR9-3HG-222-19aa-3,MIR9-3HG-226-19aa-3,MIR9-3HG-227-19aa-3,MIR9-3HG-233-19aa-2,MIR9-3HG-241-19aa-3,MIR9-3HG-246-19aa-3,MIR9-3HG-247-19aa-1,MIR9-3HG-251-19aa-3,MIR9-3HG-252-19aa-3,MIR9-3HG-253-19aa-2)
Grand Average of Hydropathicity 0.4789
Relative Molecular Mass 2524.8
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000654079;MIR9-3HG-212
Transcript Length 4019
Coding Ability 0.521
DNA Sequence Corresponding to Peptide ATGGTGGATAGGTCTTGGCTCCCAGTTTCCTTCTGGGCAGACATTGCCCCTCTGCCC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :